Nuwellis to Host Webinar Discussing ULTRA-Peds Registry Results and Aquadex Performance in Critically Ill Pediatric Patients
Key Highlights
- ➤Nuwellis will host ULTRA-Peds registry results webinar December 1, 2026
- ➤ULTRA-Peds study accepted for publication in Pediatric Nephrology
- ➤Approximately 86% of complete-data cases reached planned treatment duration
- ➤Early circuit terminations primarily involved vascular access problems or clotting
- ➤Aquadex indicated for pediatric patients weighing 20 kilograms or more
Expert Statements
Mike McCormick, President and Chief Executive Officer of Nuwellis
“Managing fluid overload in critically ill children presents unique challenges, particularly given the complexity of treating smaller and more vulnerable patients.”
Mike McCormick, President and Chief Executive Officer of Nuwellis
“The ULTRA-Peds Registry provides valuable real-world insights into the use of Aquadex in pediatric care, and we believe it is important to bring the clinical community together to discuss these findings.”
Mike McCormick, President and Chief Executive Officer of Nuwellis
“This webinar reflects our ongoing commitment to advancing clinical education, fostering collaboration, and helping healthcare professionals make informed decisions when managing complex fluid conditions.”
MINNEAPOLIS, Nov. 19, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today announced that it will host a live educational webinar, "ULTRA-Peds Results Analysis and Discussion," on December 1, 2026, at 1:00 p.m. Eastern Time. The event will feature a panel of lead and contributing authors of the multicenter study titled "Kidney Support in Infants and Children using Aquadex: Findings from the ULTRA-Peds Registry,” which was recently accepted for publication in Pediatric Nephrology, to discuss key findings and their implications for pediatric fluid management.
"Managing fluid overload in critically ill children presents unique challenges, particularly given the complexity of treating smaller and more vulnerable patients," said Mike McCormick, President and Chief Executive Officer of Nuwellis. "The ULTRA-Peds Registry provides valuable real-world insights into the use of Aquadex in pediatric care, and we believe it is important to bring the clinical community together to discuss these findings. This webinar reflects our ongoing commitment to advancing clinical education, fostering collaboration, and helping healthcare professionals make informed decisions when managing complex fluid conditions."
Get started
Create a free account to read the full story.
